Clinical trials
Phase 3 Condylomata Acuminata trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
39 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 6 |
| Unknown status | 6 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 14 |
| Shanghai Bovax Biotechnology Co., Ltd. | 7 |
| Xiamen University | 4 |
| Assiut University | 2 |
| Graceway Pharmaceuticals, LLC | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beijing Health Guard Biotechnology, Inc | 1 |
| Catalysis SL | 1 |
| Huazhong University of Science and Technology | 1 |
| MediGene | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Condylomata Acuminata | 39 |
| Uterine Cervical Neoplasms | 22 |
| Vaginal Neoplasms | 11 |
| Papillomavirus Infections | 10 |
| Vulvar Neoplasms | 10 |
| Anus Neoplasms | 5 |
| Adenocarcinoma in Situ | 1 |
| Penile Neoplasms | 1 |
| Recurrence | 1 |
| Uterine Cervical Dysplasia | 1 |
Trials
Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.